Are you Dr. Bharucha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-456-5959Fax+1 214-456-5649
Summary
- Dr. Kamal Bharucha, MD is a pediatric endocrinologist in Dallas, Texas. He is currently licensed to practice medicine in Texas, California, and Maryland.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Endocrinology, 2002 - 2005
- Johns Hopkins UniversityResidency, Pediatrics, 1998 - 2001
- Yale School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2018 - 2026
- TX State Medical License 2008 - 2012
- MD State Medical License 2001 - 2002
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- 49 citationsCatch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III TrialFabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto, Rayfel Schneider, Ricardo Machado Xavier
Arthritis & Rheumatology. 2015-03-01 - 19 citationsSubcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.Nicolino Ruperto, Hermine I. Brunner, Athimalaipet V Ramanan, Gerd Horneff, Ruben Cuttica
Rheumatology. 2021-10-02 - 16 citationsEfficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.Hermine I. Brunner, Nicolino Ruperto, Zbigniew Zuber, Ruben Cuttica, Vladimir Keltsev
Arthritis & Rheumatology. 2021-02-09